Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 27,000 | |||
5 mg | 在庫あり | ¥ 66,000 | |||
10 mg | 在庫あり | ¥ 105,000 | |||
25 mg | 在庫あり | ¥ 173,000 | |||
50 mg | 在庫あり | ¥ 243,500 | |||
100 mg | 在庫あり | ¥ 328,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 98,000 |
説明 | Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM). |
ターゲット&IC50 | RLK:1.2 nM, EGFR:520 nM, BLK:6.3 nM, BTK:1.3 nM, ERB4:11.3 nM, BMX:1.0 nM, ITK:440 nM, TEC:0.8 nM, ErbB2:3900 nM |
別名 | PRN1008 |
分子量 | 665.76 |
分子式 | C36H40FN9O3 |
CAS No. | 1575596-29-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 130 mg/mL (195.27 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rilzabrutinib 1575596-29-0 Angiogenesis JAK/STAT signaling Others Tyrosine Kinase/Adaptors EGFR HER BTK inhibit PRN-1008 PRN 1008 Inhibitor Btk PRN1008 Bruton tyrosine kinase inhibitor